Truist Financial Stock Intrinsic Value – Jazz Pharmaceuticals’ Buy Rating Reaffirmed by Truist Financial
December 7, 2023
🌥️Trending News
Truist Financial ($NYSE:TFC) recently reaffirmed its buy rating for Jazz Pharmaceuticals. Truist Financial is a financial services company that provides a variety of banking, lending, investment, and insurance services. Their stock is traded on the New York Stock Exchange under the ticker symbol TFC. Jazz Pharmaceuticals is a global biopharmaceutical company that focuses on developing and commercializing medicines to meet critical medical needs. The company has a strong portfolio of drugs and treatments, and their innovative approach to healthcare is highly regarded.
The reassertion of Truist Financial’s buy rating on Jazz Pharmaceuticals is a positive signal for the company’s future prospects. The rating shows that Truist Financial has confidence in Jazz Pharmaceuticals’ ability to continue innovating and delivering quality products and services to the healthcare industry. With Truist Financial’s support, Jazz Pharmaceuticals should be able to continue their success in providing safe and effective treatments to those in need.
Stock Price
The stock opened at $33.1 and closed at $33.2, down 0.4% from its prior closing price of $33.3. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Truist Financial. More…
| Total Revenues | Net Income | Net Margin |
| – | 5.33k | – |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Truist Financial. More…
| Operations | Investing | Financing |
| 9.79k | 7.1k | -9.28k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Truist Financial. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 542.71k | 480.7k | – |
Key Ratios Snapshot
Some of the financial key ratios for Truist Financial are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 22.4% | – | – |
| FCF Margin | ROE | ROA |
| – | – | – |
Analysis – Truist Financial Stock Intrinsic Value
At GoodWhale, we take a deep dive into the financials of companies, such as TRUIST FINANCIAL, to help investors make informed decisions. Using our proprietary Valuation Line, we have determined that the intrinsic value of TRUIST FINANCIAL shares is around $50.3. However, the current price of TRUIST FINANCIAL stock is $33.2, making it undervalued by 33.9%. We believe that this presents an opportunity for investors to purchase TRUIST FINANCIAL stock at a discounted rate. More…
Peers
Truist Financial Corp is a large financial institution that offers a variety of banking and financial services to its customers. Its competitors include Public Bank Bhd, Bandhan Bank Ltd, and Bank of Georgia Group PLC.
– Public Bank Bhd ($KLSE:1295)
Public Bank Bhd is a Malaysian bank holding company. It was founded in 1966 and is headquartered in Kuala Lumpur. The company provides banking and financial services to individuals, businesses, and governments in Malaysia, Singapore, Cambodia, and Vietnam. Public Bank Bhd has a market cap of 84.24B as of 2022. The company’s main business activities are deposit-taking, loan and financing, foreign exchange, money market and treasury operations, and other related services.
– Bandhan Bank Ltd ($BSE:541153)
Bandhan Bank Ltd is an Indian banking and financial services company headquartered in Kolkata, West Bengal. It was founded in 2001 by Chandra Shekhar Ghosh. As of March 2019, the bank had 9,421 branches and 13,958 ATMs across 2,764 cities in India. Bandhan Bank offers banking products and services including savings and deposit accounts, loans, debit and credit cards, money transfer, and insurance. The bank had a market capitalization of 432.67 billion as of March 2019.
– Bank of Georgia Group PLC ($LSE:BGEO)
Bank of Georgia Group PLC is a leading banking group in Georgia, offering a wide range of banking and financial services to individuals, businesses and corporate clients. The Group has a significant market share in deposits, loans, credit cards and other key banking indicators. It is also the largest non-bank financial institution in the country. The Group employs around 4,000 people and serves over 1.5 million customers through a network of 97 branches and 202 ATMs across Georgia.
Summary
Truist Financial recently reaffirmed its buy rating on Jazz Pharmaceuticals. The investment analysis from Truist Financial suggests that Jazz Pharmaceuticals has strong potential for long-term growth. They cite the company’s market leadership in the specialty pharmaceutical industry, strong financials, and robust pipeline of drugs as factors that could propel the company to continued success.
Additionally, they point to the company’s ability to make strategic acquisitions and collaborations that expand their presence in the market. They believe that Jazz Pharmaceuticals’ strong fundamentals and potential for future growth make it a great long-term investment.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
